The 'Global delta-Valerolactone (DVL, CAS 542-28-9) Market Outlook 2019-2024' offers detailed coverage of delta-valerolactone industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading delta-valerolactone producers to provide exhaustive coverage of the market for delta-valerolactone. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography.
The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global delta-valerolactone market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market.
Key Regions
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
Key Vendors
- BASF SE
- MYJ Chemical Co., Ltd.
- request free sample to get a complete list of companies
Key Questions Answered in This Report
- Analysis of the delta-valerolactone market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on delta-valerolactone vendors including products, sales/revenues, SWOT, and market position, recent developments.
- Market structure, market drivers and restraints.
Part 1. Summary
Part 2. Report Methodology
2.1 Methodology
2.2 Data Source
Part 3. Introduction
Part 4. Industry Value Chain
4.1 delta-Valerolactone Industry Value Chain Analysis
4.2 Upstream
4.3 End-uses
4.4 Distributors
Part 5. Competitive Landscape
5.1 Global delta-Valerolactone Sales & Share by Company (2014-2019)
5.2 Global delta-Valerolactone Revenue & Share by Company (2014-2019)
5.3 Pricing Trends
5.4 Competitive Trends
Part 6. Segmentation by Type
6.1 Global delta-Valerolactone Sales Volume by Type (2014-2019)
6.2 Global delta-Valerolactone Revenue by Type (2014-2019)
6.3 Global delta-Valerolactone Price by Type (2014-2019)
Part 7. Segmentation by Application
7.1 Global delta-Valerolactone Sales Volume by Application (2014-2019)
7.2 Global delta-Valerolactone Revenue by Application (2014-2019)
7.3 Global delta-Valerolactone Price by Application (2014-2019)
Part 8. Regional Perspectives
8.1 Overview
8.2 North America
8.2.1 Market Size (Volume & Value)
8.2.2 by Application
8.2.3 by Country (U.S., Canada, Mexico, etc.)
8.3 Europe
8.3.1 Market Size (Volume & Value)
8.3.2 by Application
8.3.3 by Country (Germany, UK, France, Spain, Italy, etc.)
8.4 Asia-Pacific
8.4.1 Market Size (Volume & Value)
8.4.2 by Application
8.4.3 by Country (China, Japan, Korea, India, etc.)
8.5 Middle East & Africa
8.5.1 Market Size (Volume & Value)
8.5.2 by Application
8.5.3 by Country (Saudi Arabia, Turkey, Nigeria, Iran, South Africa, etc.)
8.6 South America
8.6.1 Market Size (Volume & Value)
8.6.2 by Application
8.6.3 by Country (Brazil, Argentina, Colombia, etc.)
Part 9. Company Profiles
9.1 Company Profile
9.2 Product Offered
9.3 Business Performance
9.4 Recent Developments
Part 10. Market Forecast
10.1 Global delta-Valerolactone Market Size Forecast (2019-2024)
10.1.1 Global delta-Valerolactone Sales Forecast (2019-2024)
10.1.2 Global delta-Valerolactone Revenue Forecast (2019-2024)
10.2 Forecast by Region
10.2.1 North America
10.2.2 Europe
10.2.3 Asia-Pacific
10.2.4 Middle East & Africa
10.2.5 South America
10.3 Forecast by Type
10.4 Forecast by Application
Part 11. Market Drivers
11.1 Opportunities
11.2 Challenges
11.3 Economic/Political Environmental
Part 12. Industry Activity
12.1 M&As, JVs and Partnership
12.2 Other Developments
Part 13. Appendix
DISCLAIMER
ABOUT GEN CONSULTING COMPANY
The global Delta Decalactone market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fi...
Asia Pacific pharmaceutical robots market will grow by 11.0% annually with a total addressable market cap of $1.5 billion (a total revenue of hardware, software, and service) over 2023-2032, driven by the benefits offered by pharmaceutical robots, growing awareness of robotic systems in manufacturin...
Europe pharmaceutical robots market was valued at $35.1 million (a total revenue of hardware, software, and service) in 2022 and will grow by 7.8% annually over 2022-2032, driven by the benefits offered by pharmaceutical robots, growing awareness of robotic systems in manufacturing process, increasi...
North America pharmaceutical robots market is projected to grow by 9.3% annually in the forecast period and reach $104.7 million (a total revenue of hardware, software, and service) by 2032, driven by the benefits offered by pharmaceutical robots, growing awareness of robotic systems in manufacturin...
Global pharmaceutical robots market will reach $434.9 million (a total revenue of hardware, software, and service) by 2032, growing by 9.6% annually over 2022-2032, driven by the benefits offered by pharmaceutical robots, growing awareness of robotic systems in manufacturing process, increasing inve...
Overview of the Global Delta-3-Carene (CAS:13466-78-9) Market:
The report discusses everything a marketer requires before investing in the global Delta-3-Carene (CAS:13466-78-9) Market during the forecast period 202...
Overview of the Global Delta Robots Market:
The report discusses everything a marketer requires before investing in the global Delta Robots Market during the forecast period 2023-2030. It provides detailed insight i...
The global Delta-3-Carene (CAS:13466-78-9) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market play...
The global Delta Robots market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field e...
Overview of the Global Gamma Delta T Cell Cancer Therapy Market:
The report discusses everything a marketer requires before investing in the global Gamma Delta T Cell Cancer Therapy Market during the forecast period...